Understanding how NGN3 affects pancreatic cell development

Investigating the role of NGN3 in Notch signaling repression during pancreatic endocrinogenesis

NIH-funded research Children's Hospital of Los Angeles · NIH-11164406

This study is looking at how a protein called NGN3 helps develop the insulin-producing cells in the pancreas, which is important for people with diabetes, by using special stem cells to learn more about how these cells grow and work together.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionChildren's Hospital of Los Angeles NIH-funded
Lab location1 site (Los Angeles, United States)
Project IDNIH-11164406 on NIH RePORTER

What this research studies

This research investigates the role of the NGN3 protein in the development of pancreatic beta cells, which are crucial for insulin production. By analyzing patient-specific stem cells, the research aims to uncover how NGN3 influences the maturation of these cells and their interactions with other cell types in the pancreas. The study employs advanced techniques like single-cell transcriptome and chromatin analyses to explore the genetic and epigenetic factors involved in pancreatic development. This could lead to improved methods for generating functional beta cells for diabetes treatment.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with type 2 diabetes who may benefit from advanced cellular therapies targeting pancreatic beta cell dysfunction.

Not a fit: Patients who do not have type 2 diabetes or those whose diabetes is not related to pancreatic beta cell dysfunction may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could enhance the effectiveness of stem cell therapies for patients with type 2 diabetes by producing more mature and functional insulin-producing cells.

How similar studies have performed: Previous research has shown promising results in understanding pancreatic cell development, but the specific role of NGN3 in this context is still being explored, making this a novel investigation.

Where this research is happening

Los Angeles, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions adult onset diabetesAdult-Onset Diabetes Mellitus
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.